Journal of Medicinal Chemistry p. 84 - 89 (1986)
Update date:2022-07-30
Topics:
Lin, Tai-Shun
Wang, Lin
Antonini, Ippolito
Cosby, Lucille A.
Shiba, David A.
et al.
A series of (o-and p-nitrobenzyloxycarbonyl)-5-fluorouracil derivatives were synthesized by reacting o- or p-nitrobenzyl chloroformate with 5-fluorouracil in the presence of triethylamine in DMF or Me2SO.The reductive activation of these agents was hypothesized to generate a reactive methide and 5-fluorouracil, two components that are capable of synergistic interaction through complementary inhibition.Measurement of the surviving fractions of EMT6 tumor cells treated with these agents in culture under conditions of hypoxia and aerobiosis resulted in equal cell kill regardless of the state of oxygenation.One of the synthesized agents, 3-(p-nitrobenzyloxycarbonyl)-5-fluorouracil (4), appeared to be superior to 5-fluorouracil in prolonging the survival time of mice bearing intraperitoneal implants of the P388 leukemia and Sarcoma 180.
View Morexi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Contact:86-510-82853889
Address:Rm.3732, No.18-2,Yonghe Rd.,Wuxi,Jiangsu,214023,China
Quzhou Ruiyuan chemical Co., Ltd
Contact:+86-570-3039321/3039361/3039308
Address:18# Huayang Road,Quzhou High-tech Industrial Park, Zhejiang China.
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Doi:10.1021/om00131a032
(1985)Doi:10.1016/S0040-4039(00)88555-X
(1990)Doi:10.1016/S0031-9422(00)83736-X
(1986)Doi:10.1021/jm00152a007
(1986)Doi:10.1021/jo00249a013
(1988)Doi:10.1016/S0040-4020(01)88656-7
(1983)